乌鸦传媒

Tirzepatide ok'd for obstructive sleep apnea in people with obesity

Compounders only have 2 to 3 months left to copy injectable

Why it's unlikely to help most people

Advisory panel had no conclusions about ultraprocessed foods or alcohol

Health news and commentary gathered by 乌鸦传媒 staff

Experts weigh in on weight regain, cardiometabolic fallout, and the future of tailored care

Existing models improved only slightly after accounting for certain female risk factors

Physicians, policymakers raise questions about LillyDirect connecting patients with telehealth

Experts tackle myths, data bias, and game-changing outcomes of obesity drugs

Dual GLP-1/GIP drug yielded an average 47% greater relative weight loss compared to semaglutide

Experts tackle access, equity, and the blockbuster drugs reshaping healthcare

Also in TTHealthWatch: minimum effective dose of pneumococcal vaccines

Federal government would pick up about three-fourths of the cost for Medicaid coverage

A conversation with bariatric surgeon Christine J. Ren-Fielding, MD